Published 1996
| Version v1
Report
Open
Correlation of clinical outcome to the estimated radiation dose from Boron Neutron Capture Therapy (BNCT)
- 1. Beth Israel Medical Center, NY (United States). Dept. of Radiation Oncology
- 2. Brookhaven National Lab., Upton, NY (United States)
Description
A phase I/II trial delivering a single fraction of BNCT using p-Boronophenylalanine-Fructose and epithermal neutrons at the the Brookhaven Medical Research Reactor was initiated in September 1994. The primary endpiont of the study was to evaluate the feasibility and safety of a given BNCT dose. The clinical outcome of the disease was a secondary endpoint of the study. The objective of this paper is to evaluate the correlation of the clinical outcome of patients to the estimated radiation dose from BNCT
Availability note (English)
Available from INIS in electronic form; ALSO AVAILABLE FROM OSTI AS DE97008894; NTIS; US GOVT. PRINTING OFFICE DEP.Files
30000426.pdf
Files
(127.6 kB)
| Name | Size | Download all |
|---|---|---|
|
md5:82f0f8cb26334ece72471a8448317500
|
127.6 kB | Preview Download |
Additional details
Publishing Information
- Imprint Pagination
- 7 p.
- Report number
- BNL--64625
Conference
- Title
- 7. international symposium on neutron capture therapy for cancer
- Dates
- 4-7 Sep 1996
- Place
- Zurich (Switzerland)
INIS
- Country of Publication
- United States
- Country of Input or Organization
- United States
- INIS RN
- 30000426
- Subject category
- S62: RADIOLOGY AND NUCLEAR MEDICINE; S61: RADIATION PROTECTION AND DOSIMETRY;
- Resource subtype / Literary indicator
- Conference
- Descriptors DEI
- BORON 10; NEOPLASMS; NEUTRON CAPTURE THERAPY; PATIENTS; PERFORMANCE; PHENYLALANINE; RADIATION DOSES
- Descriptors DEC
- AMINO ACIDS; ANIMALS; AROMATICS; BORON ISOTOPES; CARBOXYLIC ACIDS; DISEASES; ISOTOPES; LIGHT NUCLEI; MAMMALS; MAN; MEDICINE; NEUTRON THERAPY; NUCLEI; ODD-ODD NUCLEI; ORGANIC ACIDS; ORGANIC COMPOUNDS; PRIMATES; RADIOTHERAPY; STABLE ISOTOPES; THERAPY; VERTEBRATES
Optional Information
- Contract/Grant/Project number
- Contract AC02-76CH00016
- Funding organization
- USDOE Office of Energy Research, Washington, DC (United States)
- Secondary number(s)
- CONF-9609293--